CpG hypermethylation of collagen type I α 2 contributes to proliferation and migration activity of human bladder cancer
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
In our microarray screening of methylated genes in bladder cancer (BC), the collagen type 1 alpha 2 (COL1A2) gene was the most up-regulated among the 30,144 genes screened. We hypothesize that inactivation of the COL1A2 gene through CpG methylation contributes to proliferation and migration activity of human BC. We subjected a bladder cancer cell line (BOY) and 67 BC specimens and 10 normal bladder epitheliums (NBEs) to conventional or real-time methylation quantitative polymerase chain reaction (PCR) and to real-time reverse transcriptase (RT)-PCR. We also established a stable COL1A2 transfectant for evaluating cell proliferation and migration activity. After 5-aza-dC treatment, the expression levels of COL1A2 mRNA transcript markedly increased in BOY. Our cell proliferation assays consistently demonstrated growth inhibition in the COL1A2 transfectant compared with control and wild-type BOY cells (p<0.0001). Wound healing assays also showed significant wound healing inhibition in the COL1A2 transfectant compared to the counterparts (p=0.0016). We demonstrated by bisulfite DNA sequencing that the promoter hypermethylation of COL1A2 was a frequent event in clinical BCs. The methylation index of COL1A2 was significantly higher in the 67 BCs than in the 10 NBEs (p=0.0011). Conversely, COL1A2 mRNA transcript was significantly lower in the BCs than in the NBEs (p=0.0052). The mechanism of COL1A2 down-regulation in BC is through CpG hypermethylation of the promoter region. COL1A2 gene inactivation through CpG hypermethylation may contribute to proliferation and migration activity of BC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection and interpretation of altered methylation patterns in cancer cells
Ushijima, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1571 · Cited by 483 · cited 1×
“Recent intensive study of the epigenetic change of gene promoter hypermethylation has shown that it is an important molecular mechanism contributing to tumor suppressor gene inactivation in human cancer (3).”
Background
Cited by
Spatial transcriptomics at subspot resolution with BayesSpace
Zhao, E., Stone, M. R., Ren, X., Guenthoer, J., Smythe, K. S., Pulliam, T., Williams, S. R., Uytingco, C. R., Taylor, S. E. B., Nghiem, P., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00935-2 · Cited by 1,005
Hayashi, M., Nomoto, S., Hishida, M., Inokawa, Y., Kanda, M., Okamura, Y., Nishikawa, Y., Tanaka, C., Kobayashi, D., Yamada, S., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-108 · Cited by 101
“COL1A2 gene expression was epigenetically down-regulated in medulloblastoma [27], melanoma [28,29], head and neck cancer [30], and bladder cancer [31].”
BackgroundIdentification of epigenetically regulated genes that predict patient outcome in neuroblastoma
Carén, H., Djos, A., Nethander, M., Sjöberg, R.-M., Kogner, P., Enström, C., Nilsson, S., & Martinsson, T. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-66 · Cited by 74
“COL1A2 7q22 Type I collagen Medulloblastoma, colorectal- breastand bladder cancer, melanoma [13,21,23,29] Tumors that secrete the gene have low tumorigeneic potential [27].”
Kim, M.-K., Kim, E. J., Cheng, Y., Shin, M. H., Oh, J.-H., Lee, D. H., & Chung, J. H. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.02.005 · Cited by 21
COL1A2 is a TBX3 target that mediates its impact on fibrosarcoma and chondrosarcoma cell migration
Omar, R., Cooper, A., Maranyane, H. M., Zerbini, L., & Prince, S. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.06.004 · Cited by 21
Metadata
- Authors
- Enokida
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2009-05-07
- Volume
- 34
- Issue
- 6
- Pages
- 1593-602
- ISSN
- 1019-6439 (ISSN-L)
- OpenAlex
- W2096839583
- Cited by
- 52
- References
- 1
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CpG hypermethylation of collagen type I α 2 contributes to proliferation and migration activity of human bladder cancer. https://app.cochat.ai/papers/10.3892/ijo_00000289
- The paper
- Enokida. (2009). CpG hypermethylation of collagen type I α 2 contributes to proliferation and migration activity of human bladder cancer. International Journal of Oncology. https://doi.org/10.3892/ijo_00000289
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.